|
1
|
Huan J, Hornick NI, Goloviznina NA, Kamimae-Lanning AN, David LL, Wilmarth PA, Mori T, Chevillet JR, Narla A, Roberts CT, Loriaux MM, Chang BH, Kurre P. Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes. Leukemia 2015; 29:2285-95. [PMID: 26108689 DOI: 10.1038/leu.2015.163] [Citation(s) in RCA: 89] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2015] [Revised: 05/19/2015] [Accepted: 06/11/2015] [Indexed: 12/20/2022]
Abstract
We recently demonstrated that acute myeloid leukemia (AML) cell lines and patient-derived blasts release exosomes that carry RNA and protein; following an in vitro transfer, AML exosomes produce proangiogenic changes in bystander cells. We reasoned that paracrine exosome trafficking may have a broader role in shaping the leukemic niche. In a series of in vitro studies and murine xenografts, we demonstrate that AML exosomes downregulate critical retention factors (Scf, Cxcl12) in stromal cells, leading to hematopoietic stem and progenitor cell (HSPC) mobilization from the bone marrow. Exosome trafficking also regulates HSPC directly, and we demonstrate declining clonogenicity, loss of CXCR4 and c-Kit expression, and the consistent repression of several hematopoietic transcription factors, including c-Myb, Cebp-β and Hoxa-9. Additional experiments using a model of extramedullary AML or direct intrafemoral injection of purified exosomes reveal that the erosion of HSPC function can occur independent of direct cell-cell contact with leukemia cells. Finally, using a novel multiplex proteomics technique, we identified candidate pathways involved in the direct exosome-mediated modulation of HSPC function. In aggregate, this work suggests that AML exosomes participate in the suppression of residual hematopoietic function that precedes widespread leukemic invasion of the bone marrow directly and indirectly via stromal components.
Collapse
Affiliation(s)
- J Huan
- Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA.,Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA.,Oregon Stem Cell Center, Oregon Health & Science University, Portland, OR, USA
| | - N I Hornick
- Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA.,Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA.,Oregon Stem Cell Center, Oregon Health & Science University, Portland, OR, USA
| | - N A Goloviznina
- Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA.,Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA.,Oregon Stem Cell Center, Oregon Health & Science University, Portland, OR, USA
| | - A N Kamimae-Lanning
- Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA.,Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA.,Oregon Stem Cell Center, Oregon Health & Science University, Portland, OR, USA
| | - L L David
- Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, OR, USA
| | - P A Wilmarth
- Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, OR, USA
| | - T Mori
- Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
| | - J R Chevillet
- Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - A Narla
- Division of Hematology/Oncology, Stanford University, Palo Alto, CA, USA
| | - C T Roberts
- Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA.,Department of Medicine, Oregon Health & Science University, Portland, OR, USA.,Oregon National Primate Research Center, Beaverton, OR, USA
| | - M M Loriaux
- Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.,Department of Medicine, Oregon Health & Science University, Portland, OR, USA
| | - B H Chang
- Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA.,Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
| | - P Kurre
- Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA.,Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR, USA.,Oregon Stem Cell Center, Oregon Health & Science University, Portland, OR, USA.,Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA
| |
Collapse
|